121 related articles for article (PubMed ID: 1784589)
1. DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists.
Watson NV; Gorzalka BB
Pharmacol Biochem Behav; 1991 Jul; 39(3):605-12. PubMed ID: 1784589
[TBL] [Abstract][Full Text] [Related]
2. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
Klint T; Dahlgren IL; Larsson K
Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
[TBL] [Abstract][Full Text] [Related]
3. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
Foreman MM; Hall JL; Love RL
Life Sci; 1989; 45(14):1263-70. PubMed ID: 2811596
[TBL] [Abstract][Full Text] [Related]
4. Relation of spontaneous wet dog shakes and copulatory behavior in male rats.
Watson NV; Gorzalka BB
Pharmacol Biochem Behav; 1990 Dec; 37(4):825-9. PubMed ID: 2093184
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
Jenck F; Broekkamp CL; Van Delft AM
Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
[TBL] [Abstract][Full Text] [Related]
6. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
8. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats.
Schechter LE; Simansky KJ
Psychopharmacology (Berl); 1988; 94(3):342-6. PubMed ID: 3128809
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
13. A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat.
Rahman W; Bannister K; Bee LA; Dickenson AH
Brain Res; 2011 Mar; 1382():29-36. PubMed ID: 21276431
[TBL] [Abstract][Full Text] [Related]
14. Concurrent wet dog shaking and inhibition of male rat copulation after ventromedial brainstem injection of the 5-HT2 agonist DOI.
Watson NV; Gorzalka BB
Neurosci Lett; 1992 Jul; 141(1):25-9. PubMed ID: 1508396
[TBL] [Abstract][Full Text] [Related]
15. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
Meltzer HY; Simonovic M; Gudelsky GA
Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
Arnt J; Hyttel J
Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
19. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
[TBL] [Abstract][Full Text] [Related]
20. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
